Wednesday, March 28, 2012

The promise of induced pluripotent stem cells in research and therapy.

Nature. 2012 Jan 18;481(7381):295-305. doi: 10.1038/nature10761.

Robinton DA, Daley GQ.
Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Keywords: stem-cell biology, reprogramming technology, pluripotency, reprogramming factors, personalized regenerative cell therapies, embryonic stem cells, therapeutic potential.